Cancer research of wisconsin and northern michigan (crown) consortium

Ended Cooperative Agreement Awarded Last action

Award ID
UG1CA239769
Recipient
Awarding agency
Obligated
$20,801,688

Award facts

Assistance listing
93.399 Cancer Control
Completion date
Originally
Funding
  • $19,065,242.00 Federal
  • $1,736,446.00 Non-federal
Place of performance
Green Bay, WI 54301, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment $0 $0
Amendment $2,644,022 $0
Amendment $2,025,783 $0
Amendment $2,128,916 $0
Amendment $2,128,916 $0
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment $2,276,003 $0
Amendment $2,276,003 $0
Amendment $1,736,446 $0
Amendment $1,736,446 $1,736,446
Amendment $0 $0
Amendment $0 $0
Amendment $0 $0
Amendment Cancer research of wisconsin and northern michigan (crown) consortium - the cancer research of wisconsin and northern michigan (crown) consortium is a… $0 $0
Amendment $0 $0
Amendment $1,290,000 $0
Amendment $0 $0
Amendment $0 $0
Original award $822,707 $0
Show all 21

Subawards

Subrecipient Amount Awarded
Aspirus Wausau Hospital, Inc. Aspirus will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer care delivery… $328,296
Aspirus Wausau Hospital, Inc. $1,276,707
Columbia ST. Mary's, Inc. Ascension Wisconsin will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer… $255,016
Columbia ST. Mary's, Inc. $1,276,707
Columbia ST. Mary's, Inc. Ascension will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer care delivery… $591,204
Aspirus, Inc. Aspirus will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer care delivery… $690,704
Columbia ST. Mary's, Inc. Ascension will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer care delivery… $626,617
Aspirus, Inc. Aspirus will advance the NCORP by actively participating in NCORP and NCI's National Clinical Trials Network (NCTN) trials, and executing cancer care delivery… $642,595

Quick answers

Who received award UG1CA239769?

UG1CA239769 was awarded to ST. Vincent Hospital Of The Hospital Sisters Of The Third Order Of ST. Francis by National Cancer Institute (National Institutes of Health) on August 23, 2019.

How much is award UG1CA239769 worth?

$20,801,688 has been obligated on UG1CA239769: $19,065,242 in federal funding and $1,736,446 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login